喀什男的一定要割包茎嘛(喀什哪有治疗妇科医院) (今日更新中)

SAN FRANCISCO, Sept. 13 (Xinhua) -- Researchers in San Francisco, U.S. have found in a latest study that bisphenol A (BPA) and methylparaben, two chemicals commonly used in consumer products, can interfere with the breast cancer drugs, local media reported on Tuesday.In the study, doctors from California Pacific Medical Center in San Francisco found that healthy breast cells from high-risk patients started to find ways to bypass breast cancer drugs after they were exposed to BPA and methylparaben in the lab.The cells exposed to the two chemicals kept growing and didn't die after they were introduced with Tamoxifen, a current standard drug therapy for female breast cancer and most common used treatment for male breast cancer, Dr. William Goodson, lead author of the study, told San Francisco Chronicle.Goodson said that BPA and methylparaben not only mimic estrogen 's ability to drive cancer, but appear to be even better than the natural hormone in bypassing the ability of drugs to treat it. The finds have been published online in the British medical journal Carcinogenesis.The research shows more evidence of safety issues of BPA, a chemical primarily used to make plastic baby bottles, food containers, household electronics and etc, as well as the less known methylparaben, a chemical preservative used in cosmetics and other personal care products.The researchers noted that the breast cancer rates have been growing by about the same amount in men as in women over the past three decades. Scientists have been looking at environmental causes for the disease and wondering where the hormones are coming from.Goodson said BPA and methylparaben are used so widely and even found in household dust, noting that it is still unknown whether the effects of exposure to the chemicals are reversible.Since 2008, several governments issued reports questioning the negative health effects of BPA, especially raising concerns regarding exposure of fetuses, infants and children. BPA use has been banned in baby bottles in a lot of countries and regions.As for methylparaben, the U.S. Food and Drug Administration said on its website that "at the present time there is no reason for consumers to be concerned about the uses of cosmetics containing parabens (including methylparaben)."

BEIJING, Aug. 22 (Xinhuanet) -- U.S. presidential candidate Rick Perry's controversial stem-cell treatment may inspire desperate patients to follow his lead while causing medical and legal concerns, according to media reports Monday.The Texas governor underwent a procedure on July 1 where stem cells, made from fat taken from his body, were put into his bloodstream to see if they might find their way to fix a bad back.The treatment carries potential risks ranging from blood clots to infection to cancer and may even run afoul of federal rules, doctors say. File photo of U.S. Republican presidential candidate Texas Governor Rick Perry."As a highly influential person of power, Perry’s actions have the unfortunate potential to push desperate patients into the clinic of quacks,” Harvard’s stem cell expert George Daley told the Associated Press.Worries about the safety and wisdom of this treatment are widespread among stem cell researchers as such a treatment has not been thoroughly vetted by researchers or approved by the FDA.

WASHINGTON, Aug. 10 (Xinhua) -- After a journey of almost three years, NASA's Mars rover Opportunity has reached the Red Planet's Endeavour crater to study rocks never seen before, the U.S. National Aeronautics and Space Administration (NASA) announced on Wednesday.Scientists hope it will find rocks and terrain much older than any other that the itinerant robot has examined during its seven years on the red planet.The U.S. space agency said that Opportunity arrived at the rim of Endeavour on Tuesday. The golf cart-size rover is expected to remain at the 22-kilometer-wide crater for the next few years.A portion of the west rim of Endeavour crater sweeps southward in this color view from NASA's Mars Exploration Rover Opportunity."NASA is continuing to write remarkable chapters in our nation' s story of exploration with discoveries on Mars and trips to an array of challenging new destinations," NASA Administrator Charles Bolden said in a statement. "Opportunity's findings and data ... will play a key role in making possible future human missions to Mars and other places where humans have not yet been."NASA's Mars Reconnaissance Orbiter, which has been circling the planet since late 2005, detected clay minerals that form in wet conditions in the crater. Scientists want to find out if the minerals date back to Mars' distant past, when the planet is believed to have been wetter and warmer than the dry frozen desert it is today."We're soon going to get the opportunity to sample a rock type the rovers haven't seen yet," said Matthew Golombek, Mars Exploration Rover science team member, at NASA's Jet Propulsion Laboratory in Pasadena, Calif. "Clay minerals form in wet conditions so we may learn about a potentially habitable environment that appears to have been very different from those responsible for the rocks comprising the plains."NASA is searching for signs that Mars had a habitable environment billions of years ago. Knowledge of the Martian climate will be important to future manned missions there, and can shed light on the forces that shaped Earth's climate.NASA launched the Mars rovers Opportunity and Spirit in 2003 for what were planned to be three-month missions. But both continued operating well beyond that. Spirit stopped communicating in March 2010.

BEIJING, Aug. 22 (Xinhuanet) -- U.S. presidential candidate Rick Perry's controversial stem-cell treatment may inspire desperate patients to follow his lead while causing medical and legal concerns, according to media reports Monday.The Texas governor underwent a procedure on July 1 where stem cells, made from fat taken from his body, were put into his bloodstream to see if they might find their way to fix a bad back.The treatment carries potential risks ranging from blood clots to infection to cancer and may even run afoul of federal rules, doctors say. File photo of U.S. Republican presidential candidate Texas Governor Rick Perry."As a highly influential person of power, Perry’s actions have the unfortunate potential to push desperate patients into the clinic of quacks,” Harvard’s stem cell expert George Daley told the Associated Press.Worries about the safety and wisdom of this treatment are widespread among stem cell researchers as such a treatment has not been thoroughly vetted by researchers or approved by the FDA.

SAN FRANCISCO, June 22 (Xinhua) -- Apple Inc. has been awarded a long sought-after patent for touch screen functionality on portable devices, a set of exclusive rights expected to play into its current litigation against its counterparts in the mobile device market, U.S. media reported on Wednesday."A computer-implemented method, for use in conjunction with a portable multifunction device with a touch screen display, comprises displaying a portion of page content, including a frame displaying a portion of frame content and also including other content of the page, on the touch screen display," the U.S. Patent and Trademark Office patent abstract reads.Apple filed for the patent in December, 2007.Apple's patent essentially gives it ownership of the capacitive multitouch interface the company pioneered with its iPhone, on- line computer magazine PCMag quoted a source who has been involved in intellectual property litigation on similar matters as saying.The latest patent could produce a new round of lawsuits over the now-ubiquitous multitouch interfaces used in smartphones made by the likes of HTC, Samsung, Motorola, Research in Motion, Nokia, and others that run operating systems similar in nature to Apple's iOS, like Google's Android, said the patent expert.Apple has not immediately responded to request for comment on whether it will use the latest patent against competitors.Apple is currently involved in several patent-related battles with other companies. Nokia sued Apple in October 2009 for allegedly infringing patents the Finnish phone maker owns related to wireless handsets.Apple countersued Nokia in December 2009, accusing Nokia of infringing 13 Apple patents related to the iPhone. Nokia lodged a complaint later with the U.S. International Trade Commission, charging Apple of infringing seven Nokia patents "in virtually all of its mobile phones, portable music players and computers."Last Monday, Nokia said Apple had agreed to pay the Finnish company a license fee to settle all patent litigation between the two. Industry watchers said Nokia is likely to get around 608 million U.S. dollars from Apple.This April, Apple filed a lawsuit against Samsung, alleging that the Korean consumer electronics company has violated Apple's intellectual property in the design of its mobile devices, such as iPhone and iPad.Samsung later sued Apple separately in Asia, Europe and the United States, accusing Apple of infringing Samsung's 10 patents related to mobile phones.

来源：资阳报